151 related articles for article (PubMed ID: 16472771)
1. Structural separation of different extracellular activities in aminoacyl-tRNA synthetase-interacting multi-functional protein, p43/AIMP1.
Han JM; Park SG; Lee Y; Kim S
Biochem Biophys Res Commun; 2006 Mar; 342(1):113-8. PubMed ID: 16472771
[TBL] [Abstract][Full Text] [Related]
2. The activity of aminoacyl-tRNA synthetase-interacting multi-functional protein 1 (AIMP1) on endothelial cells is mediated by the assembly of a cytoskeletal protein complex.
Jackson VC; Dewilde S; Albo AG; Lis K; Corpillo D; Canepa B
J Cell Biochem; 2011 Jul; 112(7):1857-68. PubMed ID: 21416500
[TBL] [Abstract][Full Text] [Related]
3. Identification of CD23 as a functional receptor for the proinflammatory cytokine AIMP1/p43.
Kwon HS; Park MC; Kim DG; Cho K; Park YW; Han JM; Kim S
J Cell Sci; 2012 Oct; 125(Pt 19):4620-9. PubMed ID: 22767513
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 4-mediated c-Jun N-terminal kinase activation induces gp96 cell surface expression via AIMP1 phosphorylation.
Kim G; Han JM; Kim S
Biochem Biophys Res Commun; 2010 Jun; 397(1):100-5. PubMed ID: 20510162
[TBL] [Abstract][Full Text] [Related]
5. The tRNA-interacting factor p43 associates with mammalian arginyl-tRNA synthetase but does not modify its tRNA aminoacylation properties.
Guigou L; Shalak V; Mirande M
Biochemistry; 2004 Apr; 43(15):4592-600. PubMed ID: 15078106
[TBL] [Abstract][Full Text] [Related]
6. Aminoacyl-tRNA synthetase interacting multi-functional protein 1 attenuates liver fibrosis by inhibiting TGFβ signaling.
Ahn J; Son MK; Jung KH; Kim K; Kim GJ; Lee SH; Hong SS; Park SG
Int J Oncol; 2016 Feb; 48(2):747-55. PubMed ID: 26692190
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity and pharmacokinetic properties of ARS-interacting multi-functional protein 1 (AIMP1/p43).
Han JM; Myung H; Kim S
Cancer Lett; 2010 Jan; 287(2):157-64. PubMed ID: 19573982
[TBL] [Abstract][Full Text] [Related]
8. Aminoacyl-tRNA synthetase-interacting multi-functional protein, p43, is imported to endothelial cells via lipid rafts.
Yi JS; Lee JY; Chi SG; Kim JH; Park SG; Kim S; Ko YG
J Cell Biochem; 2005 Dec; 96(6):1286-95. PubMed ID: 16167337
[TBL] [Abstract][Full Text] [Related]
9. Stepping Out of the Cytosol: AIMp1/p43 Potentiates the Link Between Innate and Adaptive Immunity.
Liang D; Halpert MM; Konduri V; Decker WK
Int Rev Immunol; 2015; 34(5):367-81. PubMed ID: 26325028
[TBL] [Abstract][Full Text] [Related]
10. Translation initiation from two in-frame AUGs generates mitochondrial and cytoplasmic forms of the p43 component of the multisynthetase complex.
Shalak V; Kaminska M; Mirande M
Biochemistry; 2009 Oct; 48(42):9959-68. PubMed ID: 19775078
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice.
Kim TS; Lee BC; Kim E; Cho D; Cohen EP
Vaccine; 2008 Nov; 26(47):5928-34. PubMed ID: 18793691
[TBL] [Abstract][Full Text] [Related]
12. The novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair.
Park SG; Shin H; Shin YK; Lee Y; Choi EC; Park BJ; Kim S
Am J Pathol; 2005 Feb; 166(2):387-98. PubMed ID: 15681823
[TBL] [Abstract][Full Text] [Related]
13. Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines.
Bottoni A; Vignali C; Piccin D; Tagliati F; Luchin A; Zatelli MC; Uberti EC
J Cell Physiol; 2007 Aug; 212(2):293-7. PubMed ID: 17443684
[TBL] [Abstract][Full Text] [Related]
14. Jekyll & Hyde: evolution of a superfamily.
Martinis SA; Joy Pang YL
Chem Biol; 2007 Dec; 14(12):1307-8. PubMed ID: 18096496
[TBL] [Abstract][Full Text] [Related]
15. The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein.
Xu H; Malinin NL; Awasthi N; Schwarz RE; Schwarz MA
J Biol Chem; 2015 Apr; 290(15):9753-66. PubMed ID: 25724651
[TBL] [Abstract][Full Text] [Related]
16. AIMP1 negatively regulates adipogenesis by inhibiting PPARγ.
Kim JH; Lee JH; Park MC; Yoon I; Kim K; Lee M; Choi HS; Han JM; Kim S
J Cell Sci; 2014 Oct; 127(Pt 20):4483-93. PubMed ID: 25146391
[TBL] [Abstract][Full Text] [Related]
17. Structure of the ArgRS-GlnRS-AIMP1 complex and its implications for mammalian translation.
Fu Y; Kim Y; Jin KS; Kim HS; Kim JH; Wang D; Park M; Jo CH; Kwon NH; Kim D; Kim MH; Jeon YH; Hwang KY; Kim S; Cho Y
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15084-9. PubMed ID: 25288775
[TBL] [Abstract][Full Text] [Related]
18. Swapping of three-dimensional domains as a molecular mechanism of dimerization of aminoacyl-tRNA synthetases.
Deniziak MA; Barciszewski J
IUBMB Life; 2002 Aug; 54(2):85-8. PubMed ID: 12440524
[TBL] [Abstract][Full Text] [Related]
19. Complementation of yeast Arc1p by the p43 component of the human multisynthetase complex does not require its association with yeast MetRS and GluRS.
Golinelli-Cohen MP; Zakrzewska A; Mirande M
J Mol Biol; 2004 Jun; 340(1):15-27. PubMed ID: 15184019
[TBL] [Abstract][Full Text] [Related]
20. Degradation of AIMP1/p43 induced by hepatitis C virus E2 leads to upregulation of TGF-β signaling and increase in surface expression of gp96.
Kim MS; Kim S; Myung H
PLoS One; 2014; 9(5):e96302. PubMed ID: 24816397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
